Navigating Regulatory and Market Access Strategies in Cell and Gene Therapy

Please join Holland & Knight's Life Sciences Team and the Marwood Group for a timely webinar on regulatory and market access strategies in the cell and gene therapy space. Several industry professionals will share their experiences and provide valuable insights and updates on current trends and future projections.

Our panel will discuss topics such as the potential impact of the Trump Administration, legislative dynamics and the Orphan Drug Tax Credit (ODTC), as well as how to approach pipeline prioritization, go-to-market strategies, pricing and value-based contracting. We will also examine supply chain and manufacturing dynamics, the potential for state action and label expansion opportunities using decentralized clinical trials (DCTs) and real-world evidence (RWE).

Speakers

Michael Werner  |  Partner, Holland & Knight
Sara Klock  |  Associate, Holland & Knight
Stephen Williams  |  Director, Marwood Group
Nayan Ghosh  |  Head of Life Sciences and HealthTech, Marwood Group
Sumin Koo  |  Healthcare Executive and Strategy Consultant, Marwood Group
Mark Slomiany  |  Advisory Director, Marwood Group